Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.
AptarGroup, Inc. (ATR) delivers innovative dispensing systems and packaging solutions for pharmaceutical, beauty, and consumer goods markets worldwide. This page provides centralized access to official company announcements, financial updates, and industry developments.
Investors and stakeholders will find timely updates including earnings reports, product innovations, and strategic partnerships. Our curated news collection simplifies tracking regulatory milestones and market trends impacting AptarGroup's core segments: Pharma, Beauty, and Closures.
All content is sourced from verified corporate communications and reputable financial publications. Bookmark this page for efficient monitoring of ATR's operational developments, sustainability initiatives, and leadership changes within the global packaging industry.
AptarGroup, Inc. (NYSE: ATR) announced the schedule for its quarterly conference calls for the year 2022, with press releases issued after trading hours. Key dates include:
- 4th Quarter and Annual Results: February 17, 2022, with a call on February 18, 2022, at 8:00 a.m. CT
- 1st Quarter Results: April 28, 2022, with a call on April 29, 2022, at 8:00 a.m. CT
- 2nd Quarter Results: July 28, 2022, with a call on July 29, 2022, at 8:00 a.m. CT
- 3rd Quarter Results: October 27, 2022, with a call on October 28, 2022, at 8:00 a.m. CT
AptarGroup, Inc. (NYSE: ATR) has been recognized as the top company on Forbes' inaugural Green Growth 50 list for 2021. This accolade highlights Aptar's commitment to reducing greenhouse gas emissions while achieving earnings growth. Aptar aims to have over 60% of its facilities certified as Landfill Free by year-end and emphasizes the importance of sustainable solutions in its business strategies. The company focuses on recyclability, renewable energy, and sustainable product design in collaboration with organizations like the Ellen MacArthur Foundation.
AptarGroup, Inc. (NYSE:ATR) reported a 9% increase in Q3 2021 sales, reaching $825 million, mainly from strong performance in Beauty + Home and Food + Beverage. Adjusted earnings per share (EPS) were $0.94, down from $1.01 a year ago, due to restructuring and investment losses. The Pharma segment experienced slight sales declines, impacted by lower demand in prescription markets. The company completed acquisitions enhancing its capabilities in medical and digital solutions. Looking ahead, EPS is projected between $0.88 and $0.96 for Q4, with focus on cost containment amid rising inflation.
AptarGroup, Inc. (NYSE:ATR) announced that its patented Cartridge Pump System (CPS) has been reviewed by the U.S. FDA for use in Oyster Point Pharma's TYRVAYA™ Nasal Spray, the first FDA-approved nasal treatment for dry eye disease. This approval marks a significant milestone, confirming Aptar's expertise in drug delivery solutions. The CPS is designed for multidose delivery of both preserved and non-preserved formulations, aiding in the treatment of symptoms associated with dry eye disease, impacting approximately 38 million adults in the U.S.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.38 per share, with a payment date set for November 17, 2021. Shareholders of record as of October 27, 2021, are eligible for this dividend. The company will also host a conference call on October 29, 2021, at 8:00 a.m. CT to discuss its third quarter results. Aptar, headquartered in Crystal Lake, Illinois, specializes in drug delivery and consumer product dispensing solutions.
AptarGroup, Inc. (NYSE: ATR) will host a virtual Capital Markets Day on September 10, 2021, starting at 9:00 a.m. EDT. Senior executives will present and participate in a Q&A session. Interested parties can access the event via the Investor Relations page. A replay will be available for 30 days post-event. Aptar is a leader in drug delivery and consumer product dispensing, operating in various markets such as pharmaceutical and beauty, with a workforce of 13,000 across 20 countries.
AptarGroup, Inc. (NYSE: ATR) announced the passing of Dr. Joanne Smith, a long-time member of its Board of Directors, who served since 1999. Dr. Smith was also the Chairwoman of the Corporate Governance Committee and was revered for her deep market insights and leadership style. Her contributions significantly impacted Aptar's success over the past 22 years, as noted by Chairman George Fotiades and President & CEO Stephan B. Tanda. The company appreciates her guidance and expresses deep gratitude for her commitment.